Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | +37.44% | -7.21% | -26.43% |
May. 09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
May. 09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | 1.2M | Sales 2025 * | 1.5M | Capitalization | 113M |
---|---|---|---|---|---|
Net income 2024 * | -163M | Net income 2025 * | -154M | EV / Sales 2024 * | 233 x |
Net Debt 2024 * | 167M | Net Debt 2025 * | 243M | EV / Sales 2025 * | 238 x |
P/E ratio 2024 * |
-0.61
x | P/E ratio 2025 * |
-1
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on Seres Therapeutics, Inc.
1 day | +37.44% | ||
1 week | -7.21% | ||
Current month | +3.98% | ||
1 month | +45.19% | ||
3 months | -8.04% | ||
6 months | +1.98% | ||
Current year | -26.43% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 14-10-31 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 20-10-21 |
Chief Tech/Sci/R&D Officer | - | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 15-03-31 |
Director/Board Member | 68 | 23-01-03 | |
Richard Kender
BRD | Director/Board Member | 68 | 14-10-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | +2.89% | - | |
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.7494 | -32.49% | 15,045,030 |
24-05-07 | 1.11 | -6.72% | 6,829,813 |
24-05-06 | 1.19 | +2.59% | 6,223,908 |
24-05-03 | 1.16 | +4.50% | 4,464,739 |
24-05-02 | 1.11 | +2.78% | 3,254,754 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.43% | 113M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- MCRB Stock